Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review. - sprookjes - yvandenbroek - TriplyDB

Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.

Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.

http://www.wikidata.org/entity/Q38613525

about

miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.miR-142-5p Disrupts Neuronal Morphogenesis Underlying Porcine Hemagglutinating Encephalomyelitis Virus Infection by Targeting Ulk1.Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma.MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.MicroRNA-145 regulates platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration by targeting CD40.An ANCCA/PRO2000-miR-520a-E2F2 regulatory loop as a driving force for the development of hepatocellular carcinoma A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.Role of microRNA-7 and selenoprotein P in hepatocellular carcinoma.MiR-24-3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M.MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/β-catenin pathway in hepatocellular carcinoma.Downregulation of miR‑136‑5p in hepatocellular carcinoma and its clinicopathological significance.Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma.Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.MicroRNA-188-3p is involved in sevoflurane anesthesia-induced neuroapoptosis by targeting MDM2.MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells.miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway.MicroRNA-125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection.Preparation and characterization of the Adriamycin-loaded amphiphilic chitosan nanoparticles and their application in the treatment of liver cancer.Assessing the Off-Target Effects of miRNA Inhibitors on Innate Immune Toll-Like Receptors.Anticancer effect of miR-96 inhibitor in bladder cancer cell lines.RNA-binding protein AUF1 suppresses miR-122 biogenesis by down-regulating Dicer1 in hepatocellular carcinoma.miRNA-146a rs2910164 C>G polymorphism increased the risk of esophagogastric junction adenocarcinoma: a case–control study involving 2,740 participants.Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise

P2860

Q24658453-C1E73976-2DD0-4031-ADD0-CA73E4939F03 Q33556403-937D075B-321D-40E2-B672-A287755D167B Q33627765-DD11FAC8-3145-49EE-8C45-F4943D089D39 Q33905532-B8339834-A28B-452F-B60C-7DDE077B13B3 Q36866382-9A1B91D9-B5DD-476E-A9E9-4BAD259965DB Q36879604-18643CB9-5315-49C1-95A6-F5A441C49322 Q37096235-05985584-20FA-44B8-84AF-523A43CFE979 Q38430715-D6AA78C5-FAA5-4E09-9B11-8F52B0582C85 Q38705380-D0D8EA41-3476-4B66-8F55-B642C8FBA0CF Q38744683-E73C846E-7944-41E2-A2B4-61F7D1660495 Q42371572-9FC67AEB-542C-4E81-9B6A-72D2CC5821FC Q42679004-2277DA77-C61D-48C3-9287-99DCA3323792 Q46588142-1CA4DABB-FF47-41EF-BA23-D410C40EF908 Q47215507-3BA72FEB-6247-402C-B985-FA0CD54F320B Q47712108-511778E2-50A1-4DB0-9E13-EB658BB45FE1 Q47950411-9DD23FDD-32CA-4540-99F0-7E79BF743C7D Q49209465-90C15B8C-DCCA-4EEF-9F1D-ED5BC7F3AB41 Q49565823-D572F20C-69E6-4E0E-BC08-7E27C649E1CD Q49836380-237004FA-249B-46E2-BAAA-7F62E7DD1BE7 Q51282064-2F94F653-266F-47D1-8337-B2B421B766C1 Q52691371-9EB7C1F4-8ACA-4F93-8352-9B2C91C25466 Q54245388-F3467CBE-DD33-4FAE-B738-3BF8C4D68A53 Q55441072-29B45E9D-BD0D-4430-B5AF-D9A331B3AE0F Q58764682-2FFE4CD5-907F-4558-8369-47AE4499334E

P2860

Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.

http://www.wikidata.org/entity/Q38613525

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.

@en

type

label

Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.

@en

prefLabel

Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.

@en

P1433

Q38613525-2F14B00C-2FD2-4DCC-8C6C-B225D00A804F

P1476

Q38613525-C8120A18-7DE2-43C0-A0A1-D05BC0BF13C8

P2093

Q38613525-6D56E5CC-C8E4-42E4-AABC-8D8C01D82202

Q38613525-A10BE353-75FC-49EF-8B89-EC1F71FF99EC

Q38613525-D29A561F-F4A1-4962-8F3D-BE67AF73671F

Q38613525-F6EADE98-ADC7-4652-AE39-742F25D2D674

P2860

Q38613525-06270C47-43A0-4CE5-8E5A-92749D40919B

Q38613525-08FBB0F5-B010-4545-BD60-049943A135B2

Q38613525-0B1853DF-5D39-4971-976C-BE2C3877BA96

Q38613525-0BAA57BD-2EA9-46C2-AEA0-2EDCD567264E

Q38613525-10EB0BE2-2C65-4861-99DF-7CD36CFF3436

Q38613525-15CB3D10-2422-411F-8999-BA532BBDFF14

Q38613525-17B9EC29-3B4B-4382-AFD0-C63FAFEA4315

Q38613525-18BD7DA4-79BE-46AC-A61F-083CAF36518C

Q38613525-195494FA-7093-4B39-81B6-897020D8FA4C

Q38613525-1ADE0F8B-6A1D-4607-9F67-8FF5474E744D

P304

Q38613525-C9B470C5-B93C-42A3-8AF8-37C8D62BCE70

P31

Q38613525-36B842A0-8E75-43F7-85BA-86C2D89531EF

P356

Q38613525-D9412F9C-5CB7-45DB-9269-204B67F93333

P433

Q38613525-6BCF4985-8D9A-466B-BBB6-B6B91E259990

P478

Q38613525-5795E2B8-3CB0-43B6-869F-F89C54041E15

P577

Q38613525-9CB3926C-5A47-4103-B983-03F1DA012202

P698

Q38613525-57359721-F63F-4B67-A616-5E24E711E21A

P356

P1433

Hepatology Research

P1476

Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.

@en

P2093

Eiji Uchida

http://www.w3.org/2001/XMLSchema#string

Hiroshi Yoshida

http://www.w3.org/2001/XMLSchema#string

Toshihiro Takizawa

http://www.w3.org/2001/XMLSchema#string

Yoshiaki Mizuguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion

miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism

miR-126 regulates angiogenic signaling and vascular integrity

Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells

Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221

miR-221 overexpression contributes to liver tumorigenesis

MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

Circulating microRNAs as stable blood-based markers for cancer detection.

MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1

P304

391-406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HEPR.12606

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26490438

http://www.w3.org/2001/XMLSchema#string